The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
基本信息
- 批准号:8843334
- 负责人:
- 金额:$ 316.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-02 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAffectAgingAmericasAreaArtsBaltimoreBudgetsClinicalCollaborationsCommunicable DiseasesCommunitiesComorbidityCritiquesDeveloping CountriesDevelopmentDisciplineDiseaseEducation and OutreachEpidemicFertilizationFundingGoalsGrantGrowthHIVHealth ResourcesInstitutionInternationalIntervention StudiesKnowledgeLeadershipLiquid substanceMedicalMentorsNIH Grants and ContractsNeurologyNursing SchoolsPrincipal InvestigatorProductivityPublic HealthPublic Health NursesPublic Health NursingPublic Health SchoolsRecruitment ActivityResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesSchool NursingSchoolsScienceStructureStudy SectionSubstance abuse problemTranscendUnderrepresented MinorityUniversitiesWorkbasecareerco-infectioncombatglobal healthinnovationmedical schoolsnext generationnovelpandemic diseaseprogramsresponseworking group
项目摘要
This is a revision of a new application to re-establish a Center for AIDS Research (CFAR) at the Johns
Hopkins University (JHU). The new CFAR is comprised of more than 180 investigators from across all
divisions of JHU and is based on a large portfolio of domestic and international HIV/AIDS research projects,
with a Research Funding Base of $85 million for 165 grants to 136 Principal Investigators. This submission
has been extensively revised on the basis of the critique of our 2010 application. We now propose six cores
and three scientific working groups that will provide s a productive platform for promoting collaboration and
synergy across the JHU HIV research community. The aims ofthe JHU CFAR are to 1) Enhance integration
and productivity of JHU HIV/AIDS research by promoting trans-disciplinary innovation and collaboration
across disciplines and university divisions; 2) Recruit new investigators into HIV/AIDS research to address
the growing need for knowledge in rapidly emerging areas that affect the AIDS epidemic, e.g., co-infections,
co-morbidities, substance abuse, and aging; 3) Provide mentoring forth next generation of HIV/AIDS
researchers and to recruit underrepresented minority investigators through mentoring and developmental
grants; and 4) Mobilize the capacity of JHU to combat the HIV epidemic in Baltimore through engagement,
training, outreach and community-based intervention studies. These aims will be addressed across three
broad themes: Development and Mentoring of New Investigators, Addressing the Baltimore HIV Epidemic,
and Strengthening International Collaborations. We have garnered institutional commitments of $450,000
per year from the Provost and Deans of the medical, public health and nursing schools and $600,000 for
leveraging recruitment of HIV investigators from Departments. This new CFAR represents a major
commitment of investigators and institutional leadership to promote excellence, productivity and growth of
HIV research and control efforts at JHU, in Baltimore and globally.
这是对在约翰斯重新建立艾滋病研究中心(CFAR)的新申请的修订
霍普金斯大学。新的CFAR由来自世界各地的180多名调查人员组成
JHU各司,以大量国内和国际艾滋病毒/艾滋病研究项目为基础,
拥有8,500万元的研究经费基础,向136名首席调查员发放165笔补助金。本意见书
在对我们2010年申请的批评的基础上进行了广泛的修改。我们现在建议使用六核
以及三个科学工作组,将为S提供一个促进合作和
JHU艾滋病毒研究界的协同效应。JHU CFAR的目标是1)加强一体化
通过促进跨学科创新和合作,提高JHU艾滋病毒/艾滋病研究的效率
跨学科和大学分部;2)招募新的艾滋病毒/艾滋病研究人员,以解决
对影响艾滋病流行的迅速出现的领域的知识的需求日益增长,例如混合感染,
共病、药物滥用和衰老;3)为下一代艾滋病毒/艾滋病患者提供指导
研究人员,并通过指导和发展招募代表性不足的少数族裔调查人员
赠款;以及4)通过参与调动JHU在巴尔的摩抗击艾滋病毒流行病的能力,
培训、外展和基于社区的干预研究。这些目标将分三个阶段实现
广泛的主题:发展和指导新的调查人员,解决巴尔的摩艾滋病毒流行问题,
以及加强国际合作。我们已经获得了45万美元的机构承诺
每年从医学、公共卫生和护理学校的教务长和院长那里获得600,000美元
利用从部门招聘艾滋病毒调查员的机会。这一新的CFAR代表着一项重大的
调查人员和机构领导层致力于促进卓越、生产力和增长
JHU、巴尔的摩和全球的艾滋病毒研究和控制工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard E. Chaisson其他文献
Efficacy of Engineering Controls in Reducing Occupational Exposure to Aerosolized Pentamidine
- DOI:
10.1378/chest.102.6.1764 - 发表时间:
1992-12-01 - 期刊:
- 影响因子:
- 作者:
Melissa A. McDiarmid;John Schaefer;Cindy Lynn Richard;Richard E. Chaisson;Byron S. Tepper - 通讯作者:
Byron S. Tepper
The Impact of Prophylaxis on Outcome and Resource Utilization in <em>Pneumocystis carinii</em> Pneumonia
- DOI:
10.1378/chest.107.4.1018 - 发表时间:
1995-04-01 - 期刊:
- 影响因子:
- 作者:
Joel E. Gallant;Sharon M. McAvinue;Richard D. Moore;John G. Bartlett;David L. Stanton;Richard E. Chaisson - 通讯作者:
Richard E. Chaisson
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
药物敏感型肺结核的风险分层治疗
- DOI:
10.1038/s41467-024-53273-7 - 发表时间:
2024-10-30 - 期刊:
- 影响因子:15.700
- 作者:
Vincent K. Chang;Marjorie Z. Imperial;Patrick P. J. Phillips;Gustavo E. Velásquez;Payam Nahid;Andrew Vernon;Ekaterina V. Kurbatova;Susan Swindells;Richard E. Chaisson;Susan E. Dorman;John L. Johnson;Marc Weiner;Amina Jindani;Thomas Harrison;Erin E. Sizemore;William Whitworth;Wendy Carr;Kia E. Bryant;Deron Burton;Kelly E. Dooley;Melissa Engle;Pheona Nsubuga;Andreas H. Diacon;Nguyen Viet Nhung;Rodney Dawson;Radojka M. Savic - 通讯作者:
Radojka M. Savic
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review
- DOI:
10.1007/s40265-024-02131-3 - 发表时间:
2024-12-28 - 期刊:
- 影响因子:14.400
- 作者:
Violet Chihota;Makaita Gombe;Amita Gupta;Nicole Salazar-Austin;Tess Ryckman;Christopher J. Hoffmann;Sylvia LaCourse;Jyoti S. Mathad;Vidya Mave;Kelly E. Dooley;Richard E. Chaisson;Gavin Churchyard - 通讯作者:
Gavin Churchyard
Richard E. Chaisson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard E. Chaisson', 18)}}的其他基金
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10431020 - 财政年份:2022
- 资助金额:
$ 316.19万 - 项目类别:
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10593142 - 财政年份:2022
- 资助金额:
$ 316.19万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
10268586 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10226377 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10413161 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防 HIV 未感染者结核病的安全性和耐受性
- 批准号:
10631078 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10018455 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
9322787 - 财政年份:2012
- 资助金额:
$ 316.19万 - 项目类别: